Active not recruiting
A Study of Baricitinib in Participants With Systemic Lupus Erythematosus
I4V-MC-JAIA - ClinicalTrials.gov - NCT03616964
The reason for this study is to see how effective and safe the study drug known as baricitinib is in participants with systemic lupus erythematosus (SLE).
How long will I be in the trial?
The study will last up to 62 weeks and may include up to 17 visits.
Active not recruiting
A Study of Baricitinib in Participants With Systemic Lupus Erythematosus
I4V-MC-JAIA - ClinicalTrials.gov - NCT03616964
The reason for this study is to see how effective and safe the study drug known as baricitinib is in participants with systemic lupus erythematosus (SLE).
How long will I be in the trial?
The study will last up to 62 weeks and may include up to 17 visits.
Key Requirements
Age :
18+
Sex:
All
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Age
18+
Sex
All
Participants must
Participants must have had systemic lupus erythematosus (SLE or lupus) for at least 6 months
Participants must have currently active manifestations of lupus
Participants must NOT
Participants must not have severe lupus nephritis
Participants must not have severe central nervous system lupus
Participants must not have or have had another serious medical condition
Trial Summary
Conditions the trial is for
Lupus
What the trial is testing?
Baricitinib, Placebo
Could I receive a Placebo?
yes
Enrollment Goal
750
Trial Dates
August 2018 - November 2021
Trial Phase
3
Enter your postal code to find the nearest site
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Age
18+
Sex
All
Participants must
Participants must have had systemic lupus erythematosus (SLE or lupus) for at least 6 months
Participants must have currently active manifestations of lupus
Participants must NOT
Participants must not have severe lupus nephritis
Participants must not have severe central nervous system lupus
Participants must not have or have had another serious medical condition
Trial Summary
Conditions the trial is for
Lupus
What the trial is testing?
Baricitinib, Placebo
Could I receive a Placebo?
yes
Enrollment Goal
750
Trial Dates
August 2018 - November 2021
Trial Phase
3
Not the right fit? Sign up to receive updates on new Lupus trials.
Trial Locations
Hide locations not currently recruiting
Enter your postal code to see sites near you
Lupus Resources
